No change in N-acetyl aspartate in first episode of moderate depression after antidepressant treatment: (1)H magnetic spectroscopy study of left amygdala and left dorsolateral prefrontal cortex.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4179760)

Published in Neuropsychiatr Dis Treat on September 17, 2014

Authors

Maja Bajs Janović1, Petra Kalember2, Spiro Janović1, Pero Hrabač2, Petra Folnegović Grošić3, Vladimir Grošić4, Marko Radoš5, Neven Henigsberg6

Author Affiliations

1: University Department of Psychiatry, Clinical Hospital Center Zagreb, Zagreb, Croatia ; University North, Varaždin, Croatia.
2: Polyclinic Neuron, Croatian Institute for Brain Research, School of Medicine, University of Zagreb, Zagreb, Croatia.
3: University Department of Psychiatry, Clinical Hospital Center Zagreb, Zagreb, Croatia.
4: Psychiatric Hospital Sveti Ivan, Zagreb, Croatia.
5: University Department of Radiology, Clinical Hospital Center Zagreb, Zagreb, Croatia.
6: Polyclinic Neuron, Croatian Institute for Brain Research, School of Medicine, University of Zagreb, Zagreb, Croatia ; Psychiatric Clinic Vrapče, Zagreb, Croatia.

Articles cited by this

A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89

An inventory for measuring depression. Arch Gen Psychiatry (1961) 84.61

A new depression scale designed to be sensitive to change. Br J Psychiatry (1979) 36.40

Neurobiology of depression. Neuron (2002) 8.56

Neurobiology of emotion perception I: The neural basis of normal emotion perception. Biol Psychiatry (2003) 6.93

Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct (2008) 6.32

Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry (1999) 5.63

Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry (2001) 5.11

Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A (1998) 4.16

Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry (2000) 4.03

Neuroimaging studies of mood disorders. Biol Psychiatry (2000) 3.92

Depression: perspectives from affective neuroscience. Annu Rev Psychol (2002) 3.72

Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci (1993) 3.07

Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog Brain Res (2000) 2.52

Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets (2007) 2.26

The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry (2003) 2.19

Neural responses to happy facial expressions in major depression following antidepressant treatment. Am J Psychiatry (2007) 1.92

Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol Psychiatry (2007) 1.91

Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res (1999) 1.51

Functional coupling of the amygdala in depressed patients treated with antidepressant medication. Neuropsychopharmacology (2007) 1.48

Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis. Psychiatry Res (2006) 1.46

Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry (2001) 1.46

Clinical applications of magnetic resonance spectroscopy. Magn Reson Q (1994) 1.42

Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res (2003) 1.39

Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry (1997) 1.37

Measuring depression: comparison and integration of three scales in the GENDEP study. Psychol Med (2007) 1.31

Frontal activations associated with accessing and evaluating information in working memory: an fMRI study. Neuroimage (2003) 1.31

MR spectroscopic studies of the brain in psychiatric disorders. Curr Top Behav Neurosci (2012) 1.24

Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by 1H-MRS at 3 Tesla. Invest Radiol (2003) 1.17

Through the looking glass: examining neuroanatomical evidence for cellular alterations in major depression. J Psychiatr Res (2009) 1.17

Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response. Int J Neuropsychopharmacol (2008) 1.10

Stress and hippocampal abnormalities in psychiatric disorders. Eur Neuropsychopharmacol (2004) 1.08

Orbitofrontal cortex volume in late life depression: influence of hyperintense lesions and genetic polymorphisms. Psychol Med (2007) 1.07

Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy. Am J Psychiatry (2002) 1.05

Abnormal cingulate and prefrontal cortical neurochemistry in major depression after electroconvulsive therapy. Biol Psychiatry (2010) 1.01

Focal and lateralized subcortical abnormalities in unipolar major depressive disorder: an automated multivoxel proton magnetic resonance spectroscopy study. Biol Psychiatry (2003) 1.00

The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients. Prog Neuropsychopharmacol Biol Psychiatry (2005) 1.00

Ventromedial prefrontal spectroscopic abnormalities over the course of depression: a comparison among first episode, remitted recurrent and chronic patients. J Psychiatr Res (2010) 0.94

Hippocampal metabolic abnormalities at first onset and with recurrent episodes of a major depressive disorder: a proton magnetic resonance spectroscopy study. Neuroimage (2009) 0.93

The biochemistry of dysfunctional emotions: proton MR spectroscopic findings in major depressive disorder. Prog Brain Res (2006) 0.91

Hippocampal abnormalities of glutamate/glutamine, N-acetylaspartate and choline in patients with depression are related to past illness burden. J Psychiatry Neurosci (2013) 0.86

Proton magnetic resonance spectroscopy of late-life major depressive disorder. Psychiatry Res (2009) 0.85

Antidepressant effect detected on proton magnetic resonance spectroscopy in drug-naïve female patients with first-episode major depression. Psychiatry Clin Neurosci (2009) 0.84

The effects of antidepressants on human brain as detected by imaging studies. Focus on major depression. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.84

1H Magnetic resonance spectroscopy study of dorsolateral prefrontal cortex in unipolar mood disorder patients. Psychiatry Res (2005) 0.83

Magnetic resonance spectroscopy in the evaluation of treatment efficacy in unipolar major depressive disorder: a review of the literature. Funct Neurol (2012) 0.83

Effects of antidepressant treatment on N-acetyl aspartate and choline levels in the hippocampus and thalami of post-stroke depression patients: a study using (1)H magnetic resonance spectroscopy. Psychiatry Res (2010) 0.82

Biochemical abnormalities of the medial temporal lobe and medial prefrontal cortex in late-life depression. Psychiatry Res (2009) 0.82

Changes in brain metabolites measured with magnetic resonance spectroscopy in antidepressant responders with comorbid major depression and posttraumatic stress disorder. Coll Antropol (2011) 0.82

Early increase in marker of neuronal integrity with antidepressant treatment of major depression: 1H-magnetic resonance spectroscopy of N-acetyl-aspartate. Int J Neuropsychopharmacol (2012) 0.80

Neurochemical metabolites in prefrontal cortex in patients with mild/moderate levels in first-episode depression. Neuropsychiatr Dis Treat (2013) 0.79

Normal metabolite levels in the left dorsolateral prefrontal cortex of unmedicated major depressive disorder patients: a single voxel (1)H spectroscopy study. Psychiatry Res (2009) 0.79

Hippocampal N-acetylaspartate and morning cortisol levels in drug-naive, first-episode patients with major depressive disorder: effects of treatment. J Psychopharmacol (2012) 0.78

Depressive psychosis: clinical usefulness of MR spectroscopy data in predicting prognosis. Radiology (2006) 0.78

Response time for ecallantide treatment of acute hereditary angioedema attacks. Ann Allergy Asthma Immunol (2010) 0.78

Hippocampal neurometabolite changes in depression treatment: a (1)H magnetic resonance spectroscopy study. Psychiatry Res (2012) 0.77